The use of prescribed opioid pain relievers and the risk of infections

What is it about?

The manuscript is an editorial highlighting the current understanding of the risk of infection associated with the use of prescribed opioid analgesics. The editorial summarizes the current literature on the biological basis for opioid-induced immunosuppression from animal and human studies and outlines the current literature on the risk of infection associated with the use of prescribed opioid pain relievers among human.

Featured Image

Why is it important?

It highlights recent epidemiological findings that have found the use of prescribed opioid pain reliever to be a novel risk factor for the risk of serious infections.